为控制释放和炎症应用开发带有阿托卡尔的奇托桑颗粒
Piyapan Manklinniam1, Phonchanok Reuk-Ngam2, Supavadee Boontha3
1Division of Microbiology and Parasitology, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
Polymers
|January 10, 2026
概括
这项研究开发了带有关节素的奇托桑微粒 (CSPs/AE),用于增强抗炎作用. 这种新系统证明了显著的氧化减少,显示了骨关节炎管理的潜力.
科学领域:
- 药理学和药物输送 药理学和药物输送
- 自然产品化学 自然产品化学
- 材料科学 材料科学 材料科学
背景情况:
- 阿尔托卡尔是来自*Artocarpus altilis*的一种黄,具有抗炎和老年保护性质.
- 为了提高阿托卡尔宾的稳定性和有效性,需要先进的输送系统.
- 基托微粒为药物输送提供了一个生物相容的平台.
研究的目的:
- 为了从 *Artocarpus altilis* 中心木中分离和描述 artocarpin.
- 开发和优化基托基的微粒,用于提供关节.
- 评价带有关节素的微粒的物理化学性质,体外释放和抗炎活性.
主要方法:
- 通过化和染色学净化分离阿尔托卡.
- 使用三聚酸交叉链接的奇托桑微粒配方.
- 使用HPLC,DLS,FTIR,XRD和体外释放研究进行表征.
- 在LPS刺激的RAW 264.7巨细胞中通过氧化抑制的抗炎活性的评估.
主要成果:
- 隔离的81%纯度的阿托卡;开发出稳定的基托桑微粒 (1-4μm) 具有良好的封装效率.
- FTIR和XRD证实了阿托卡因成功地被纳入基托基因组.
- 在体外研究表明,双相释放和显著,剂量依赖的氧化生产减少 (34.33-73.19%).
结论:
- 带有关节糖的奇托桑微粒 (CSP/AE) 是关节糖的一种有前途的输送系统.
- 开发的系统表现出有效的抗炎特性.
- 这种配方有可能用于管理炎症状况,如骨关节炎.
更多相关视频
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Oral Drug Delivery Systems: Delayed-Release Systems
222
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
222


